Vir Biotechnology Provides Corporate Update and Reports First Quarter 2022 Financial Results
– $1.2 billion of sotrovimab collaboration revenue recognized in the first quarter – – More…
Month: May 2022
Apellis Pharmaceuticals to Present at the Bank of America Securities 2022 Healthcare Conference
WALTHAM, Mass., May 05, 2022 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical…
Caladrius Biosciences Reports First Quarter 2022 Financial Results and Provides Business Update
Signs definitive merger agreement with Cend Therapeutics along with immediate investment and collaboration agreements Maintains…
Ventyx Biosciences to Report First Quarter 2022 Financial Results on May 12, 2022
ENCINITAS, Calif., May 05, 2022 (GLOBE NEWSWIRE) — Ventyx Biosciences, Inc. (Nasdaq: VTYX), (“Ventyx”), a…
Eledon Pharmaceuticals to Report First Quarter 2022 Financial Results on Thursday, May 12, 2022
Management to host conference call and webcast at 4:30 p.m. ET IRVINE, Calif., May 05,…
Codexis Reports First Quarter 2022 Financial Results
Total Revenue up 96% and Product Revenue up 200% YOY; Product Gross Margin Expands to…
Celyad Oncology Announces First Quarter 2022 Financial Results and Recent Business Highlights
Enrollment continues in Phase 1 dose-escalation IMMUNICY-1 trial for lead shRNA-based allogeneic CAR T candidate,…
LianBio to Participate in the Bank of America Securities 2022 Healthcare Conference
SHANGHAI, China and PRINCETON, N.J., May 05, 2022 (GLOBE NEWSWIRE) — LianBio (Nasdaq: LIAN), a…
T2 Biosystems Announces First Quarter 2022 Financial Results
Results driven by strong sepsis-focused instrument placements in the United States LEXINGTON, Mass., May 05,…
Akoya Reports First Quarter 2022 Operating Results and Raises Full Year 2022 Revenue Guidance
Q1 2022 revenue $16.9 million, 38% growth over prior year periodRaising FY 2022 revenue guidance…
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2022Â Financial Results
Corvus to Host R & D Symposium on May 10 BURLINGAME, Calif., May 05, 2022…
Gritstone Reports First Quarter 2022 Financial Results and Provides Business Update
— Clinical programs continue progressing, with multiple Phase 2 data catalysts from neoantigen oncology vaccine…
NextCure Provides Business Update and Reports First Quarter 2022 Financial Results
On track to report data from all three clinical programs in the second half of…
Longboard Pharmaceuticals Provides Corporate Update and Reports First Quarter 2022 Financial Results
Phase 1 data for LP352, a potential treatment for seizures associated with a broad range…
SIGA Reports Financial Results for Three Months Ended March 31, 2022
– First Sale of Intravenous (IV) TPOXX® to U.S. Government under the 19C BARDA Contract…
Windtree Therapeutics Reports First Quarter 2022 Financial Results and Provides Key Business Updates
Announced positive topline results from Phase 2 SEISMiC study of istaroxime in early cardiogenic shock Late-breaker…
Relay Therapeutics Reports First Quarter 2022 Financial Results and Corporate Highlights
Initiated the fulvestrant combination arm of the first-in-human trial for RLY-2608, a pan-mutant and isoform-selective…
Organogenesis Appoints Michele Korfin and Gilberto Quintero, Ph.D. to Board of Directors
CANTON, Mass., May 05, 2022 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading…
Sylogist to Discuss Performance for Q2 of Fiscal 2022
Calgary, Alberta–(Newsfile Corp. – May 5, 2022) – Sylogist Ltd. (TSX: SYZ) (“Sylogist” or the…
Steam Exchange Partners with Sheridan College Students to Help Build An Open-World Educational Metaverse Focused on Digital Assets
Toronto, Ontario–(Newsfile Corp. – May 5, 2022) – Steam Exchange, a homegrown Canadian cryptocurrency start-up,…